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The Sand Rat, Psammomys obesus, Develops Type 2
Diabetic Retinopathy Similar to Humans
Toune`s Saïdi,1,2 Sihem Mbarek,2 Samy Omri,3 Francine Behar-Cohen,3
Rafika Ben Chaouacha-Chekir,2 and David Hicks1
PURPOSE. Diabetic retinopathy (DR) is a leading cause of blind-
ness, yet pertinent animal models are uncommon. The sand rat
(Psammomys obesus), exhibiting diet-induced metabolic syn-
drome, might constitute a relevant model.
METHODS. Adult P. obesus (n  39) were maintained in captiv-
ity for 4 to 7 months and fed either vegetation-based diets (n
13) or standard rat chow (n  26). Although plant-fed animals
exhibited uniform body weight and blood glucose levels over
time, nearly 60% of rat chow–raised animals developed diabe-
tes-like symptoms (test group). Animals were killed, and their
eyes and vitreous were processed for immunochemistry.
RESULTS. Compared with plant-fed animals, diabetic animals
showed many abnormal vascular features, including vasodila-
tion, tortuosity, and pericyte loss within the blood vessels,
hyperproteinemia and elevated ratios of proangiogenic and
antiangiogenic growth factors in the vitreous, and blood-retinal
barrier breakdown. Furthermore, there were statistically signif-
icant decreases in retinal cell layer thicknesses and densities,
accompanied by profound alterations in glia (downregulation
of glutamine synthetase, glutamate-aspartate transporter, up-
regulation of glial fibrillar acidic protein) and many neurons
(reduced expression of protein kinase C and C in bipolar
cells, axonal degeneration in ganglion cells). Cone photorecep-
tors were particularly affected, with reduced expression of
short- and mid-/long-wavelength opsins. Hypercaloric diet non-
diabetic animals showed intermediate values.
CONCLUSIONS. Simple dietary modulation of P. obesus induces a
rapid and severe phenotype closely resembling human type 2
DR. This species presents a valuable novel experimental model
for probing the neural (especially cone photoreceptor) patho-
genic modifications that are difficult to study in humans and for
screening therapeutic strategies. (Invest Ophthalmol Vis Sci.
2011;52:8993–9004) DOI:10.1167/iovs.11-8423
Diabetic retinopathy (DR) is the fifth leading cause of blind-ness worldwide and the third in terms of retinal disorders
(170 million, World Health Organization). It constitutes the
leading cause of vision loss for working-age persons in devel-
oped countries.1 DR has been viewed principally as a micro-
vascular disease, and hyperglycemia induces the disruption of
cell junctions within the retinal endothelium, thickening of
basement membranes and pericyte loss.2 Vessels become leaky
and acellular, circulation is compromised leading to the forma-
tion of ischemic zones, and exudation from the capillaries
contributes to macular edema.3 However, many studies have
indicated that abnormal visual function, such as decreased
contrast sensitivity4 or color vision defects,5–7 actually precede
clinically detectable signs of retinopathy, suggesting that vas-
cular abnormalities are not the first events to occur in DR.
Numerous rodent models of DR exist, with varying degrees
of similarity to the human disease. No single animal model
recapitulates all the neural and vascular complications associ-
ated with DR, especially the late-stage proliferative form, PDR.8
Animal models can be classified as drug-induced, as with the
destruction of pancreatic beta cells by streptozotocin (SZT)8,9;
genetic, as with the widely used Ins2akita mouse strain10; and
spontaneously occurring diabetes.11 This last category includes
the sand rat P. obesus, long known to develop metabolic stress
syndrome in captivity. In contrast to animals maintained on a
natural plant-rich diet, when reared on a high-calorie regimen
many animals exhibit hallmark features of type 2 diabetes.12
The similarity between metabolic, physiological, and endo-
crine changes in this species and those occurring in human
type 2 diabetes makes it a highly relevant animal model with
which to understand the pathogenesis of this condition.13
Aside from a single study on tyrosine hydroxylase levels
during diabetes,14 retinal modifications occurring in this spe-
cies are unknown. We reasoned that, given the other numer-
ous similarities between type 2 diabetes in Psammomys and
humans, the rodents may also develop DR and serve as a novel
model for unraveling the complex pathogenesis in this blind-
ing disease. The extensive morphologic and immunochemical
studies presented here support this hypothesis.
MATERIALS AND METHODS
Experimental Animals
All animal experimentation adhered to the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research and abided by national
and local laws of ethical conduct. Young adult P. obesus were captured
in southern Tunisia using baited traps, transferred to animal facilities,
and maintained under cyclic lighting conditions (12 hours white light
[300 lux]/12 hours dark) with free access to food and water. Data
presented in this study came from two independent field excursions,
the first concerning 15 animals and the second concerning26 animals.
Male animals were separated into two groups. The low calorie diet
control group (n  5 from the first capture, n  8 from the second
capture; n  13 total) was raised on a natural diet (ND) and was fed
only halophilic plants, rich in water and mineral salts (0.4 kcal/g wet
weight). The other animals (n 10 from the first capture, n 16 from
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the second capture; n  26 total) received a standard laboratory rat
chow feed (3.3 kcal/g; Purina). Both groups were followed up for 4
months (first capture) or 7 months (second capture), with measure-
ments of their body weight, plasma glucose (One Touch Ultra Blood
Glucose Monitoring System 20247; LifeScan, Inc., Milipitas, CA), and
hematocrit every 5 days. Based on weight and glucose measurements
(see Results), a total of 15 animals from the hypercaloric groups (n 
5 from the first capture, n  10 from the second capture) were
considered diabetic (blood glucose levels200 mg/dL after 6 weeks of
diet) and termed high-protein diet diabetic (HDD). The remaining
hypercaloric animals (n  5 from the first capture, n  6 from the
second capture; n  11 total) were classified as high-protein diet
nondiabetic (HDnD). At the end of the experimental periods (4 and 7
months, respectively, for the two series), animals were euthanized by
CO2 inhalation and decapitation. Eyes were either fixed in 4% parafor-
maldehyde in PBS (0.01 M, pH 7.4) for 12 hours at 4°C or the retinas
and vitreous bodies were dissected free under a binocular microscope
and snap frozen in liquid nitrogen. Samples were processed for sec-
tioning on a cryostat (CM 3050 S; Leica, Wetzlar, Germany) using
standard protocols. For flat-mounted preparations, after fixation as
described above, the eyeballs were opened at the limbus, and the
cornea and lens were discarded. The retinas were carefully separated
from the posterior eyecup composed of the retinal pigment epithelium
(RPE), choroid, and sclera, and both tissues were washed in PBS. Radial
incisions were made in the retinas and eyecups to permit flattening.
Immunohistochemistry
Sections were processed for immunohistochemistry using conven-
tional procedures.15 Primary antibodies are listed in Table 1 and were
diluted in saturation buffer (PBS containing 0.1% bovine serum albu-
min and 0.1% Tween 20) and left overnight at 4°C. Sections were
washed and then incubated with the appropriate secondary antibod-
ies, either goat anti-rabbit or anti-mouse IgG-conjugated antibodies
coupled with Alexa 594 or Alexa 488 (Molecular Probes Ltd., Eugene,
OR) diluted 1:400. Cell nuclei were stained with 4,6-di-amino-phenyl-
TABLE 1. Antibodies Used in Immunohistochemistry and Western Blot Analysis
Antibody/Antigen Type Retinal Staining Dilution Manufacturer/Supplier
VEGF Monoclonal (mouse) — WB 0.1 g/mL Santa Cruz Biotechnology,
Santa Cruz, California
PEDF Polyclonal (rabbit) — WB 0.1 g/mL Kind gift of Joyce Tombran-Tink,
Pennsylvania State College
of Medicine, Hershey, PA
-Smooth muscle actin Monoclonal (mouse) Pericytes (blood vessels) IHC 1 g/mL Sigma Aldrich Life Sciences,
Cergy Pontoise, France
(A7607)
GFAP (whole protein from cow) Polyclonal (rabbit) Astrocytes/Mu¨ller glia IHC 2 g/mL DAKO A/S, Glostrup,
WB 0.2 g/mL Denmark (Z 0334)
Glutamine synthetase Monoclonal (mouse) Glia IHC 2 g/mL Millipore (mAb 302)
(mouse peptide) WB 0.2 g/mL
GLAST-1 (rat C-terminal peptide) Polyclonal (rabbit) Glia IHC 2 g/mL Alpha Diagnostic International
WB 0.2 g/mL (GLAST 11-S)
Neurofilament (200 kDa) Monoclonal (mouse) RGC, HC IHC 1 g/mL Sigma (N-20)
p-PKC  (human peptide) Polyclonal (rabbit) Rod and cone ON BC IHC 5 g/mL Santa Cruz Biotechnology,
sc-12894-R (Thr 410)
WB 0.5 g/mL
PKC Monoclonal (mouse) Rod and cone ON BC IHC 5 g/mL Santa Cruz Biotechnology,
(H-7) sc-8393
WB 0.5 g/mL
Parvalbumin Monoclonal (mouse) HC IHC 1 g/mL Sigma P3088
Synaptophysin (rat protein) Monoclonal (mouse) Synapses (plexiform IHC 1 g/mL Santa Cruz Biotechnology,
layers) WB 0.1 g/mL sc-12737 (SVP38)
Rhodopsin (Rho4D2) Monoclonal (mouse) ROS and RCB IHC 1 g/mL Kind gift of Robert Molday,
WB 0.1 g/mL University of British
Columbia, Vancouver, BC,
Canada
MW cone opsin Polyclonal (rabbit) COS (MW cones) IHC 1 g/mL Kind gift of Cheryl Craft,
(mouse peptide) WB 0.1 g/mL Doheny Eye Institute,
University of Southern
California, Los Angeles,
California
SW cone opsin (mouse Polyclonal (rabbit) COS (SW cones) IHC 1 g/mL Kind gift of Cheryl Craft
peptide) WB 0.1 g/mL
Peripherin (rat protein) Monoclonal (mouse) OS IHC 1 g/mL Kind gift of Robert Molday
Arrestin (cow protein) Polyclonal (rabbit) OS, CB IHC 1 g/mL Kind gift of Igal Gery,
National Institutes of
Health, Bethesda, Maryland
Recoverin Polyclonal (rabbit) OS, CB, BC IHC 1 g/mL Kind gift of Alexander
Dizhoor, Northwestern
University, Chicago, Illinois
G t1 (rod transducin) Polyclonal (rabbit) ROS, RCB IHC 1 g/mL Santa Cruz Biotechnology,
K-20 sc-389
G t2 (cone transducin) Polyclonal (rabbit) COS, CCB IHC 1 g/mL Santa Biotechnology Cruz,
I-20 sc-390
The table shows antibody/antigen type, cellular localization within the retina (if used in IHC), working dilution for IHC and WB, and
commercial origin or reference. WB, Western blot; IHC, immunohistochemistry; BC, bipolar cells; (C/R)OS, (cone/rod) outer segments; (C/R)CB,
(cone/rod) cell bodies; HC, horizontal cells; RGC, retinal ganglion cells.
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indolamine (DAPI; Sigma Aldrich Life Sciences, Cergy Pontoise,
France) diluted 1:500. Incubation was performed at room temperature
for 2 hours, and sections were washed thoroughly in PBS and cover-
slipped. Retinal and posterior eyecup wholemount immunohistochem-
istry was performed as described previously.15 Some tissues were
incubated in lectin from Bandeiraea simplicifolia directly conjugated
to tetrarhodamine isothiocyanate (25 g/mL; Sigma Aldrich Life Sci-
ences), or to phalloidin- tetrarhodamine isothiocyanate (100 g/mL;
Invitrogen-Molecular Probes, Eugene, OR) for 4 hours at room temper-
ature. Slides were examined with a fluorescence microscope (Op-
tiphot 2; Nikon, Melville, NY), and images were captured using image
analysis software (NIS-Elements BR 3.0; Nikon) or a confocal micro-
scope (LSM510 version 2.5; Carl Zeiss Meditec, Jena, Germany). Pho-
tographs were taken with identical exposure times between control
and treated specimens. Any graphics editing of images (Photoshop;
Adobe, San Jose, CA) was performed using identical parameters be-
tween the two sets. Tissues from a minimum of three animals per
group (ND, HDnD, and HDD) were examined for each condition.
Western Blot Analysis
Western blot analysis was performed on proteins extracted from entire
vitreous and retinas (n 3 per group), as described.15 After incubation
on ice for 30 minutes, proteins were suspended in Laemmli buffer and
separated by SDS-PAGE (4%–10%; 40–50 g protein/lane; total protein
concentrations were initially determined using the Bradford colorimet-
ric assay) and then transferred onto a polyvinylidene fluoride mem-
brane. Membranes were incubated with primary antibodies (Table 1)
overnight at 4°C under agitation, washed, and incubated with corre-
sponding secondary antibodies coupled to horseradish peroxidase
(1:10,000; Jackson ImmunoResearch Laboratories, West Grove, PA).
Immunoreactive bands were detected by chemiluminescence (Immo-
bilon Western; Millipore, Bedford, MA). Relative abundance was quan-
tified by scanning densitometry (ImageJ software, developed by Wayne
Rasband, National Institutes of Health, Bethesda, MD; available at
http://rsb.info.nih.gov/ij/index.html), and expressed relative to tubu-
lin immunoreactive bands in the same blots (detected after membrane
stripping and reprobing with monoclonal antitubulin antibody, diluted
1:10,000 [Jackson ImmunoResearch Laboratories]). Experiments were
performed on extracts from a minimum of three retinas from separate
animals for each group.
Measurement of Retinal Vasculature
The entire vasculature, from the optic nerve head toward the periph-
ery, was visualized on retinal flatmounts under a fluorescence micro-
scope (Optiphot 2; Nikon). The entire field was mapped using rectan-
gular grids (810.87 m2), and the surface was divided into nine
concentric zones (see Results; Fig. 3E). The retinal vascular caliber was
measured along the entire length of each major vessel, at 10 regularly
spaced points (3 m) for each rectangle, for three separate retinas
from ND, HDnD, and HDD animals. We further measured the number
of branch points in the most peripheral zone (lying beyond zone 9) for
three retinas from each ND and HDD group, averaged per square
millimeter.
Trypsin Digestion
To isolate the retinal vascular bed from fixed retinas, we followed
published procedures.16 Quantification of acellular cordlike capillaries
was performed using the criteria described by these authors, under
40 microscope objectives, using a 100  100 m grid superimposed
over 10 random fields of HD and HDD preparations. Measurement of
major vessel thickness was performed as described, beginning at the
widest (central) end of isolated vessels.
Cell Counting
The density of cell nuclei and cell layer thickness was determined for
each condition (three fields of each of three animals per group) by light
microscope examination of retinal sections. Images were obtained
within the posterior retina, within 1 mm of the optic nerve head. Cell
layer thickness and number of nuclei per layer were calculated within
a standard rectangle placed across captured images, equivalent to an
area measuring 0.07 mm2.17
Statistical Analysis
Results are expressed as mean  SD. Comparisons of the two groups
(cell counting and Western blot analyses) were performed using fac-
torial analysis of variance (ANOVA) followed by post hoc Tukey HSD
test. P 0.05 was considered statistically significant. Calculations were
performed using statistical analysis software (Statistica 8.0; StatSoft,
Maisons-Alfort, France). For vessel parameter analysis, we used two-
way ANOVA for independent and repeated measures, followed by post
hoc Tukey HSD test.
RESULTS
Development of Obesity and Hyperglycemia
Figure 1 depicts results from the second capture, involving 24
animals. Whereas body mass and blood glucose levels re-
FIGURE 1. Body weight and blood glucose evolution in P. obesus
during 7 months of captivity. Although animals reared on natural
halophilic plants (n  8, ND, filled diamonds) remained stable
throughout the entire period, of the 16 animals reared on hypercaloric
diets (standard rat chow), 10 showed steady increases in weight (dia-
betic, HDD, filled circles) (A) and glucose levels (B). The remaining six
animals demonstrated weight gain under hypercaloric conditions
(HDnD, filled squares) but did not exhibit increased blood glucose
levels relative to ND animals. Data are expressed as mean  SD. Sig-
nificant differences were determined by ANOVA (*P  0.05).
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mained stable over time in captivity in plant-fed animals (ND;
n  8), many animals raised on standard rat chow (total n 
16) became obese and developed hyperglycemia (HDD; n 
10). Six animals on high-calorie diets did not show increased
blood glucose levels (except slight increases during the final
month of captivity, which were not significantly different from
the ND values), although they showed intermediate values of
weight gain (HDnD; Fig. 1). Values for body weight (Sup-
plementary Table S1, http://www.iovs.org/lookup/suppl/
doi:10.1167/iovs.11–8423/-/DCSupplemental) and blood glucose
(Supplementary Table S2, http://www.iovs.org/lookup/suppl/
doi:10.1167/iovs.11–8423/-/DCSupplemental) for each animal as
a function of time in captivity are given in Supplementary Data,
http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-8423/-/
DCSupplemental. Although ND animals exhibited a stable weight
of 115 g throughout the experimental period, HDD animals
gained 10 to 20 g per month to reach 250 g at 7 months.
HDnD animals gained10 g per month to reach180 g in the
same period. ND animals had 80 mg/dL (5 mM) blood glu-
cose levels throughout the time in captivity, whereas HDD
animals showed permanently increasing concentrations with
monthly increments of 100 mg/dL to reach 400 mg/dL (25
mM) by 7 months (Fig. 1B). Hematocrit values for the three
groups did not vary significantly over the course of captivity or
between groups (mean 44% for both; data not shown). Results
from the first capture were largely similar, with ND, HDnD,
and HDD groups (n  5 in each group) maintained for 4
months (Supplementary Fig. S1, Table S1, http://www.iovs.
org/lookup/suppl/doi:10.1167/iovs.11-8423/-/DCSupplemental). Al-
though captivity was shorter, the HDD group increased body
weight by approximately 80% and blood glucose by 350%
compared with starting values (ND group  10% weight gain,
0% glucose increase; HDnD group  40% weight gain, 0%
glucose increase over same period).
Vitreal Protein Analysis in P. obesus
Total protein concentrations in HDD vitreous were approxi-
mately 2.2-fold greater than those of ND animals, with mean
values of 0.32 and 0.71 g/L in ND and HDD groups, respec-
tively (Table 2). Quantitative Western blots of vascular endo-
thelial growth factor (VEGF) and pigment epithelium derived
growth factor (PEDF) from each group showed highly signifi-
cant statistical differences in both cases, with VEGF values
8-fold higher, and PEDF values 100-fold lower, in HDD
animals (Fig. 2). VEGF/PEDF ratios calculated from these data
showed very large differences (up to 340-fold) between the
two groups (Table 2). VEGF and PEDF concentrations were not
studied in HDnD animals.
Vascular and Retinal-Blood Barrier Modifications
in Diabetic P. obesus
Examination of isolectin-labeled blood vessels in flat-mounted
whole retinas showed a clear demarcation into large retinal
vessels (arteries and veins) and retinal capillaries (Fig. 3). Al-
though blood vessels in the ND group showed a regularly
branching uniform aspect (Fig. 3A), HDD retinas showed a
variety of abnormal features: vessels displayed an irregular
width with alternating constrictions and dilations (Fig. 3B) as
well as focal vascular sprouts with blind ends (Fig. 3C) and
balloon-like swellings resembling microaneurysms (Fig. 3D).
Quantitative measures of major blood vessel diameter as a
function of distance from the optic nerve head (Fig. 3E)
showed that mean values for HDD were always higher than for
ND retinas and were statistically significantly different in the
midperiphery (Fig. 3F). Mean values for HDnD blood vessels
were intermediate but were not statistically significantly differ-
ent from ND values (Fig. 3F). Quantification of branch points in
the far peripheral capillaries also showed highly significant
differences between ND (119.7  19.2/mm2) and HDD
(225.5  22.8/mm2; 88% increase; P 0.001). Similar analyses
of HDnD retinas revealed intermediate values, which, although
higher than plant-fed animals, did not attain statistical signifi-
cance (190.7  29.9/mm2; P  0.059). Analysis of the retinal
vasculature after trypsin digestion revealed a regular network
of uniform capillaries in ND tissue (Fig. 3G) but the presence
of thin cord-like acellular strands in HDD samples (Fig. 3H).
Similar measures of major blood vessel diameter as performed
in intact flat-mounted retinas also showed differences in ND
and HDD thickness in isolated vascular net preparations (Fig.
3I). Furthermore, counting of acellular strands in these trypsin
digests confirmed the large differences between ND and HDD
samples (Fig. 3J). Trypsin digest experiments were not per-
formed for HDnD retinas.
Staining of ND retinal flat-mounts with isolectin (to outline
vessels) and smooth muscle actin antibody (to label pericytes)
revealed that ND blood vessels were decorated densely with
pericytes (Figs. 4A, 4B). In contrast, although HDD retinas
showed extensive isolectin staining of vessels (Fig. 4C), there
was almost complete absence of pericytes (Fig. 4D). At the
level of the blood-retina barrier within the posterior pole,
phalloidin staining of f-actin bundles within flat-mounted ND
eyecups revealed a highly regular honeycomb-like aspect of the
RPE monolayer, formed of tightly linked hexagonal cells cou-
TABLE 2. Vitreal Protein, Proangiogenic, and Antiangiogenic Growth
Factor Levels in ND and HDD P. obesus
ND
(n  8)
HDD
(n  10)
Vitreous protein levels, g/L 0.32  0.01 0.71  0.03*
Mean VEGF/PEDF ratio 0.239  0.007 71.364  7.686*
Values are mean  SD. Measurement of total soluble protein con-
tent of vitreous isolated from ND and HDD animals showed highly
significant differences, with 2.2-fold greater levels in diabetic samples.
As calculated from Western blots using anti-VEGF and anti-PEDF, ratios
of the two proteins were calculated from ND (n  8) and HDD (n 
10) individual vitreal samples.
* P  0.001.
FIGURE 2. Proangiogenic and antiangiogenic growth factors in the
vitreous of control and diabetic retinas. (A) VEGF-immunoreactive
bands in vitreous samples from three control (ND, left) and three
diabetic (HDD, right) animals. (B) PEDF-immunoreactive bands in
vitreous samples from three control (ND, left) and three diabetic
(HDD, right) animals. The bands were analyzed by densitometry and
normalized to tubulin in stripped membranes from the same samples
(shown below the VEGF/PEDF blots). Black column: relative levels in
ND controls; white column: relative levels in HDD animals. ***P 
0.001. Relative levels given in arbitrary units.
8996 Saïdi et al. IOVS, November 2011, Vol. 52, No. 12
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933459/ on 09/25/2017
pled by tight junctions (Fig. 4E). On the other hand, phalloidin
staining of HDD eyecups showed weakened junction, as evi-
denced by splitting between neighboring cells (Fig. 4F). ND
eyecups also displayed strict localization of the tight junction
marker protein kinase C (PKC) to cell borders (Fig. 4G),
whereas HDD eyecups showed generalized staining across the
cell indicative of delocalization (Fig. 4H); the same was true for
another tight junction marker, occludin (data not shown).
Additional examples of pericyte loss in diabetic retinas are
shown in Supplementary Fig. S1, http://www.iovs.org/lookup/
suppl/doi:10.1167/iovs.11-8423/-/DCSupplemental. Peri-
cyte and RPE barrier immunostaining were not performed
for HDnD retinas.
General Structural Modifications in P. obesus
The general retinal aspect of the three groups showed clear
differences. ND retinas exhibited regular layers with a thin
inner limiting basement membrane (Figs. 5A, 5B), whereas
sections of HDD retina exhibited a wider nerve fiber layer with
a membranous aspect (Fig. 5C) and displayed thin irregular
nuclear layers (Fig. 5D). This was also observed in HDnD
retinas (data not shown). Quantitative measures showed that
the widths of the outer segment (OS) layer and that of the
outer nuclear layer (ONL), inner nuclear layer (INL), and inner
plexiform layer (IPL) were significantly reduced in HDnD and
HDD retinas (by up to 40%, 36%, 38%, and 22% respectively)
(Fig. 5E). Similar reductions were noted when cell density was
counted within the ONL (up to 26% less), INL (up to 30% less),
and ganglion cell layer (GCL) (up to 44% less) (Fig. 5F).
In support of these histologic observations, plexiform layers
were clearly visualized by synaptophysin immunostaining of
synaptic vesicles. Immunolabel of the two synaptic zones was
different between ND and HDD groups. In ND retinas, the
synaptic layers were regular and linear (Fig. 5G), whereas in
HDD tissue, the OPL was irregular and the IPL was markedly
thinner (Fig. 5H). However, and in contrast to other proteins,
synaptophysin levels were significantly increased in diabetic
retinas (Fig. 5I). Synaptophysin immunoreactivity was not an-
alyzed in HDnD retinas.
Retinal Glial Modifications in P. obesus
Visualization of glial fibrillar acidic protein (GFAP) immuno-
staining at the vitreal surface of flat-mounted ND retinas
showed filamentous staining, particularly marked around
blood vessels (Fig. 6A). However, GFAP staining intensity ap-
peared higher in HDnD retinas and much higher in HDD
retinas, both along and between blood vessels (Figs. 6B, 6C).
Examination of frozen sections from each group showed that
GFAP expression was confined to the nerve fiber layer but with
more intense staining because of the hypertrophy in HDD (data
not shown). Western blot analysis of protein extracts from
each group showed a small but significant increase in intensity
FIGURE 3. Vascular modifications during diabetes in P. obesus. (A–D)
Retinas stained with B. simplicifolia isolectin. Although the vessel
aspect in control retinas (ND) showed a regular smoothly branching
aspect (A), diabetic retinas (HDD) showed a range of abnormalities,
including irregular diameter and constrictions (B, open bracket), neo-
vascular buds (C, arrow), and balloon-like swellings (D, arrow). Taken
from a confocal stacked set of images to ensure the bud was a blind
ending (C). Using a morphometric approach in which major blood
vessels were traced from the center to the periphery and were divided
into nine equivalent zones in which repeated measures of vessel width
were made (E), a significant increase in the midperiphery of HDD
vessels was observed (F, filled circles) (*P  0.05, ANOVA). HDnD
vessels (filled squares) showed diameters intermediate between those
of ND (filled diamonds) and HDD tissues, but these were not statisti-
cally significant. Trypsin-digested preparations of ND (G) and HDD (H)
tissue showed the presence of cord-like acellular strands in the dis-
eased tissue (white arrows, F). Quantitative analysis of vessel caliber in
major blood vessels in trypsin digests also showed a significant increase
in HDD tissue (I) (***P  0.001). Quantification of acellular cords in
trypsin digests showed them to be restricted to HDD tissue (***P 
0.001). Scale bars: 100 m (A, B, E, G, H); 25 m (C, D).
IOVS, November 2011, Vol. 52, No. 12 Diabetic Retinopathy in a Diurnal Rodent 8997
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933459/ on 09/25/2017
in the HDnD group compared with the ND group and in-
creases of approximately twofold in HDD compared with ND
(Fig. 6D).
In stark contrast to GFAP immunoreactivity, staining for
glutamine synthetase (GS) showed an inverse pattern. In ND
retinas, labeling was intense across the tissue, outlining the cell
bodies in the three cellular layers and filling the plexiform
layers (Fig. 6E). HDnD retinas were similar but appeared less
intense (Fig. 6F), whereas staining was greatly reduced in
sections of HDD retina, particularly in the outer half of the
tissue, with radial staining seen in individual Mu¨ller glia (Fig.
6G). Again, these qualitative differences were confirmed by
Western blot analysis and were seen to be highly significantly
different between ND and HDD samples (Fig. 6H). Glutamate-
aspartate transporter (GLAST) immunoreactivity was also in-
tense in ND retinas, extending from the Mu¨ller glial apical
microvilli through the nerve fiber layer (Fig. 6I). HDnD retinas
displayed similar patterns, although there appeared to be less
staining in the INL (Fig. 6J), whereas intensity was much
reduced in HDD retinas (Fig. 6K). Western blot analysis
showed the difference was statistically significant between ND
and HDD retinas (Fig. 6L).
Retinal Neuronal Modifications in
Diabetic P. obesus
Retinal ganglion cells (RGCs) were visualized by staining
against the 200-kDa subunit of neurofilament, in both retinal
wholemounts and frozen sections. As viewed in retinal whole-
mounts, axonal morphology differed between control and di-
abetic groups. Axons were smooth and organized into smooth
bundles in ND tissue (Fig. 7A) but exhibited numerous vari-
cosities and were often seen as individual fibers in HDD tissue
(Fig. 7B). Frozen sections of retinas from ND and HDD animals
showed a fairly similar pattern, with strong immunostaining
along the nerve fiber layer visible as discrete axon bundles in
ND (Fig. 7C) but more diffuse in HDD (Fig. 7D). HDnD RGCs
resembled those seen in ND retinas (data not shown). Bipolar
cells were stained with antibodies against PKC and PKC
(both restricted to this cell type within the neural retina). In
ND tissue, PKC immunoreactivity was present in cell bodies,
axons, and synapses of this population (Fig. 7E). The diabetic
state led to a marked reduction in staining intensity so that only
background staining was seen in HDD retinas (Fig. 7F). Quan-
tification of PKC by quantitative Western blot analysis con-
firmed a significant reduction in HDD retinas (Fig. 7G). Very
similar observations were made for PKC, with immunostain-
ing visible throughout the bipolar cells in ND (Fig. 7H) and
HDnD (albeit at reduced intensity) retinas (Fig. 7I) but was
reduced to faint synaptic staining in HDD tissue (Fig. 7J). These
qualitative results were confirmed by quantitative Western blot
analysis, with HDnD samples showing significant reductions
and HDD tissue showing highly significant reductions (Fig.
7K). Horizontal cell staining with parvalbumin antibody was
not visibly different between the groups (Figs. 7L, 7M).
Retinal Photoreceptor Modifications in Diabetic
P. obesus
There were notable differences in the responses of the two
photoreceptor populations (rods and cones) to the diabetes-
like state. Expression of rhodopsin did not differ in intensity or
distribution between the three groups (Figs. 8A–C). However,
cone mid-wavelength opsin (MOp) staining was detectably
reduced in HDD compared with ND and HDD retinas (Figs.
8D–F). This was also the case for cone short-wavelength opsin
(SOp) (Figs. 8G, 8H). These qualitative observations were all
confirmed by Western blot analysis. Rhodopsin immunostain-
ing was equal between the groups (Fig. 8I), whereas MOp and
SOp were reduced to approximately 50% the levels in HDD
FIGURE 4. Vascular and blood-reti-
nal barrier modifications during dia-
betes in P. obesus. ND retinas labeled
with B. simplicifolia lectin (Bs, red)
to outline blood vessels (A) and anti-
smooth muscle actin antibody (SMA,
green) to stain pericytes (B) demon-
strate the dense pericyte coverage
(examples shown by arrows). On
the contrary, HDD retinas labeled un-
der identical conditions showed
complete absence of pericytes (C,
D). RPE monolayer in flat-mounted
posterior eyecups (E–J). Staining
with fluorescently tagged phalloidin
to decorate F-actin was confined to
cell borders in ND (E) and HDnD (F)
eyes, but in HDD eyes there were
signs of cell splitting and separation
(arrows, G). PKC, a major compo-
nent of tight junctions, was re-
stricted to cell margins in ND (H)
and HDnD (I) eyes but was diffusely
spread across RPE in HDD eyes (J).
All images were taken in the same
focal plane, at the level of the nuclei
(E–H). Scale bar, 25 m.
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retinas (Figs. 8J, 8K). MOp levels in HDnD retinas were similar
to ND values (Fig. 8J). We examined several additional markers
of specific rod or cone types, or both, under the two experi-
mental conditions. Expression of the rod and cone OS struc-
tural protein peripherin/rds, visible uniquely in OS, was similar
between ND and HDD retinas (Supplementary Figs. S2A, S2B,
http://www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-
8423/-/DCSupplemental); arrestin staining was observed
throughout the photoreceptor layer in both retinas (Supple-
mentary Figs. S2C, S2D, http://www.iovs.org/lookup/suppl/
doi:10.1167/iovs.11-8423/-/DCSupplemental); and recoverin
was also approximately equal under both conditions (Supple-
mentary Figs. S2E, S2F, http://www.iovs.org/lookup/suppl/
doi:10.1167/iovs.11-8423/-/DCSupplemental). Both rod and
cone transducin appeared equal between the normal and
diseased conditions (Supplementary Figs. S2G–J, http://
www.iovs.org/lookup/suppl/doi:10.1167/iovs.11-8423/-/
DCSupplemental).
DISCUSSION
Diet-induced metabolic stress syndrome in the sand rat P. obesus
leads to a number of pathologic alterations in their eyes. These
modifications include a range of abnormal features associated
with control of the vasculature (within the vessels themselves:
vasodilation, increased tortuosity, vascular sprouts, occluded ves-
sels and small swellings; increased total protein and radically
opposing concentrations of VEGF and PEDF within the vitreous,
splitting of the RPE monolayer, and delocalization of tight
junction proteins forming the blood-retina barrier). There was
an extensive series of remodeling events and phenotypic
changes in retinal glia and neurons. To the extent to which
data are available for human DR, the two conditions are re-
markably similar.
There is extensive literature on the use of P. obesus as an
experimental model for investigating the development and
effects of metabolic syndrome leading to obesity, dyslipidemia,
hypertension, and type 2 diabetes.18 Studies indicate that
overly rich diets may lead to the development of hyperinsulin-
emia through ineffective extraction of excess insulin by liver
receptors. Hyperinsulinemia, in turn, causes a reversible reduc-
tion in receptor kinase activity, leading to insulin resistance.19
Furthermore, marked insulin depletion is observed in diabetic
islets, probably because of a hyperglycemia-driven increase in
secretory demand that cannot be compensated.20 The similar-
ities among metabolic, physiological, and endocrine changes in
this species compared with those in human type 2 diabetes
make it a highly relevant animal model with which to under-
stand the pathogenesis of this condition.12,13,18 In the present
study, 50% of the animals maintained on hypercaloric diets
spontaneously developed characteristics of diabetes (obesity
and elevated blood sugar levels), and all exhibited DR. The
intermediate group was not examined for every parameter, but
it displayed a variable phenotype ranging from no difference to
large differences compared with the plant-fed group. This
group experienced significant weight gains without elevated
blood glucose levels and also displayed moderate retinal symp-
toms, as indicated by reduced width and cell numbers, in-
FIGURE 5. General structural modi-
fications in P. obesus retina. General
histologic aspect of ND (A) and HDD
(C) retinas, with corresponding
DAPI-stained nuclear structures (B,
ND; D, HDD). The reduced width of
HDD retinas is apparent, together
with the less orderly organization of
the cellular layers. HDD retinas
showed a membranous appearance
of the nerve fiber layer in many sec-
tions (C, asterisk). Quantitative mea-
sures of retinal layer thickness (E)
and cell density (F) in ND (black
columns), HDnD (gray columns),
and HDD (white columns) animals.
There were significant decreases in
layer thicknesses (OS, ONL, INL, IPL)
and cell numbers (ONL, INL, GCL) in
HDD compared with ND animals
(P  0.05; ANOVA). HDnD measures
were also significantly different from
ND values for ONL, INL, and IPL for
layer width and for INL and GCL for
cell density (P  0.05; ANOVA). Syn-
aptophysin (SVP38) immunostaining
was intense in both plexiform layers
in ND (G) and HDD P. obesus (H).
Western blot analysis and quantifica-
tion of synaptophysin expression
showed it was significantly increased
in HDD retinas (I) (*P  0.05,
ANOVA). OS, outer segments. Scale
bar, 50 m (A–D, G, H).
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creased expression of GFAP, and decreased expression of
PKC. However, most of these changes were smaller than
those seen in HDD animals and were not significantly different
for GS or mid- or long-wavelength cone opsin. This intermedi-
ate group may represent latent animals who responded to
dietary imbalances with delayed-onset or refractory diabetes
compared with the HDD group. Similar percentages of diabe-
tes-susceptible (40%) and diabetes-resistant animals have been
reported in previous studies on Psammomys,21 and analysis of
the two populations has permitted identification of a major
susceptibility gene.22
A major question concerns the potential advantages and
disadvantages of this new animal model for DR. According
to the Animal Models of Diabetic Complications Consortium
(AMDCC), useful models should exhibit capillary and neuronal
loss and capillary obliteration (features of early-stage nonpro-
liferative diabetic retinopathy [NPDR]), retinal edema, and pre-
retinal neovascularization (associated with PDR). Many exper-
imental models have been developed and characterized for
their pertinence to the human disease, but most replicate only
aspects of NPDR. Some do progress to PDR, which is respon-
sible for severe vision loss but at advanced age (e.g., sponta-
neously diabetic Torii rats 50 weeks of age).23 Diet-induced
DR in Psammomys satisfies most of the criteria cited by the
AMDCC. It is typified by a range of vascular abnormalities and
widespread neuronal loss, and the presence of acellular capil-
FIGURE 6. Glial alterations in retinas of P. obesus. Immunohistochemical and Western blot analyses of glial
fibrillar acidic protein (GFAP) (A–D), glutamine synthetase (GS) (E–H), and GLAST (I–L). GFAP-containing
astrocytes were distributed across the vitreal face of flat-mounted ND retinas, especially concentrated along
major blood vessels (A). Similar views of HDnD retinas showed intense staining around blood vessels and
higher amounts between vessels (B). Observation of the vitreal face of HDD retinas showed very high numbers
of GFAP-immunopositive astrocytes across the surface (C). Increased GFAP expression in HDnD and HDD
animals was confirmed by densitometric scanning of Western blots, expressed in arbitrary units (a.u.) normal-
ized to tubulin (n 3 per retina, shown above each corresponding column) (D). Compared with ND samples
(black columns), there were large increases in HDnD (gray columns, **P  0.01, ANOVA) and HDD (white
columns, ***P 0.001, ANOVA). GS immunoreactivity was robust across the entire retina in ND (E) and HDnD
(F) animals but was greatly reduced in HDD animals (G). Western blot analysis and densitometric scans
confirmed the decreased expression for GS (H). Triplicate Western blots for GS and tubulin are shown above
each column. GLAST immunostaining was also strong in ND (I) and HDnD (J) retinas and decreased in HDD
retinas (K). As for GS, quantitative Western blots confirmed the decrease (L), and triplicate Western blots for
GLAST and tubulin are shown above the columns (***P 0.001, ANOVA). MV, Mu¨ller glial microvilli; OS, outer
segments; Tub, tubulin. Scale bars: 20 m (A–C); 50 m (E–G, I–K).
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laries indicates the formation of obliterated nonfunctional mi-
crovessels, as seen in humans.16 Psammomys showed dra-
matic pericyte loss in diabetic retinas, with almost complete
disappearance from vessel surfaces. Pericyte dropout repre-
sents the earliest detectable vascular change in animal models
of DR and is a hallmark feature of human DR.24 In the present
study, we did not specifically examine preretinal hemorrhage
and neovascularization, but two observations argue that it
develops in our model: increased vitreal protein concentra-
tions indicate leakage from new blood vessels,25 and the huge
imbalance in proangiogenic and antiangiogenic factors mea-
sured in the vitreous of diabetic animals is strongly correlated
with the development of PDR in humans.26–29 Indeed, in-
creased VEGF/PEDF ratios were directly correlated with the
degree and progression of retinal neovascularization in another
pathologic mouse model.30 We did not investigate retinal
edema in the present study because eyes were dissected and
fixed before examination. To the best of our knowledge, only
one animal model has so far been described that exhibits PDR:
the Akimba mouse, a genetic model of type 1 DR (double
transgenic Ins2akita/VEGF mice).31 It should be emphasized
that unlike the Akimba mouse, the current model is generated
solely by mild dietary overload, with no genetic overexpres-
sion of VEGF, and constitutes a faithful model of metabolic
syndrome/type 2 diabetes. Furthermore the observed changes
occurred within 7 months of hypercaloric diet, considerably
faster than the passage to PDR in other animal models.23
We especially focused on nonvascular aspects of DR be-
cause these often precede blood vessel remodeling and may be
causal events in functional decline. Such alterations are difficult
FIGURE 7. Neuronal modifications in
P. obesus retina. (A) Flat-mounted ND
retina immunostained with neurofila-
ment (NF200 kDa) antibody showing
smooth axon bundles (arrow). (B) On
the contrary, axons in HDD retinas re-
vealed moderate defasciculation and
numerous varicosities (arrow). A sim-
ilar result was seen in frozen cross-
sections, with large neurofilament-im-
munopositive bundles seen along the
nerve fiber layer in ND samples (C) but
thinner variable staining in HDD ani-
mals (D). In ND retinas, PKC anti-
body showed clear staining in cell bod-
ies within the inner nuclear layer
(INL), as well as their axons and syn-
aptic endings in the inner plexiform
layer (IPL), corresponding to rod and
cone ON bipolar cells (E). HDD retinas
showed almost complete disappear-
ance of PKC staining (F), which was
confirmed by quantitative Western
blot analysis as described earlier (trip-
licate lanes for ND and HDD retinas,
top) (G). PKC immunostaining re-
vealed a pattern similar to that of
PKC in ND retinas (H) and a less
intense signal in HDnD retinas (I),
whereas in HDD retinas residual stain-
ing was visible in the synapses (J). Re-
duced staining was again confirmed by
Western blot analysis (K). Quantitative
densitometric measurement of band
densities compared to tubulin (Tub)
confirmed the decreases in HDnD
(**P 0.01, ANOVA) and HDD (***P
0.001, ANOVA) samples. Triplicate
blots of PKC and tubulin are shown
above each corresponding column:
ND (black), HDnD (gray), HDD
(white). Histologic sections of P. obe-
sus retina immunostained with parval-
bumin antibody were very similar in
ND (L) and HDD (M) animals. OS,
outer segments. Scale bars: 20 m (A,
B); 50 m (C–F, H–J); 80 m (L, M).
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to study in a methodical manner in humans. We paid great
attention to cone photoreceptor changes because deficits in
color vision and contrast sensitivity are among the earliest
indications of DR in humans, occurring long before clinically
detectable vascular defects.5–7 We saw no significant changes
in rhodopsin levels between control and diabetic animals. In
contrast, both short-wavelength and mid-/long-wavelength
cones were strongly affected, with significant reductions in
both populations. Importantly, cone opsin expression was not
altered in the obese nondiabetic group, indicating it is causally
linked to the hyperglycemic state. Perturbations in the blue-
yellow axis have been particularly implicated in DR,7 and blue
cone dropout has been observed in postmortem human DR.32
Recent studies33 in a zebrafish model of type I NPDR revealed
that cones were highly sensitive to hyperglycemia, indepen-
dent of vascular changes. Differential susceptibility of rods and
cones in hyperglycemic conditions might be attributed to glu-
cose use; cone physiology is known to have a higher depen-
dence on correct glucose balance.34 With respect to permit-
ting detailed examination of the pathogenesis involved in cone
degeneration, P. obesus offers the major advantage of a high
cone percentage (40%)35 compared with conventional labo-
ratory rats and mice with 3% cones.36,37 Although there are
clear differences in diurnal rodent and human retina (e.g.,
rodents do not have a macula and lack a distinct long-wave-
length cone), their rod/cone ratio and axonal density in the
optic nerve resemble human central retina (Matter JM, per-
sonal communication, 2011). Their retinas have a structural
organization that facilitates quantitative measurement of rod
and cone density and survival,16,38 and visual function can be
readily followed by standard electroretinography.38 In the lat-
ter, diurnal rodents show robust photopic responses to high-
frequency flicker electroretinography, similar to that of hu-
mans but not seen in mice and rats.38
It is likely that glial malfunction is a major factor in DR.
Retinal Mu¨ller glial cells are clearly implicated in its pathogen-
esis,39 perturbation of their function impinges directly on neu-
ronal survival,40 and they are implicated in insulin signaling
and glucose metabolism in the retina.40 In the present study,
retinal glia displayed marked downregulation of two key pro-
teins involved in glutamate detoxification, GLAST and glu-
tamine synthetase (GS). Although GS showed no differences
between normal and diabetic postmortem human retinas,41
numerous studies in rodent models show clear reductions of
both.42,43 Furthermore, elevated vitreal glutamate concentra-
tions are found in both animal44 and human27 DR, indicating a
failure of glutamate metabolism. The large upregulation of the
glial stress marker GFAP is commonly seen in different models
FIGURE 8. Rod and cone photore-
ceptor opsins in P. obesus retina.
Rhodopsin (Rho) immunolabeling
showed strong expression in rod
outer segments (OS, green) in ND
(A), HDnD (B), and HDD (C) ani-
mals. Staining of cone mid wave-
length opsin (MOp) was localized to
numerous cone outer segments (OS,
red) in ND (D) and HDnD (E) ani-
mals, whereas there were many less
immunolabeled cells in HDD tissue
(F). This was also the case for cone
short wavelength (SOp) immuno-
staining in OS of ND (G) and HDD
animals (H). Western blot analysis
and quantification of Rho, MOp, and
SOp expression. (I) Rho and tubulin
(Tub) immunoreactivity showed no
difference in intensity between sam-
ples. Triplicate samples are shown
above corresponding columns: ND
(black), HDnD (gray), HDD (white).
(J) MOp immunoreactivity showed a
roughly 50% decrease in HDD retinas
when normalized to Tub (***P 
0.001, ANOVA). (K) Similarly, SOp
immunoreactivity was also reduced
by 50% in HDD retinas (***P 0.001,
ANOVA). Scale bar, 80 m.
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of retinal degeneration.45 Some reports41 show increased ex-
pression of GFAP in human DR, and all describe animal models
of DR that demonstrate an upregulation of GFAP.31,40,46,47
We observed neuronal loss in all layers, as occurs during
DR.46,48 However, because these decreases were primarily also
seen in obese nondiabetic animals, they may not be linked to
elevated glucose levels but to some other aspect of metabolic
syndrome. Ganglion cells are the best-studied neuronal type in
diabetes,48,49 and several reports show cell loss and axonal
damage in both human50 and animal46,49 models of DR. The
ganglion cell axonal swellings seen in the present study have
been observed in human DR,50 and the Ins2akita transgenic
mouse model of DR51 and are considered to indicate axonal
degeneration. To the best of our knowledge, this is the first
report of diabetes-induced decreases in PKC expression in
bipolar cells and may be related to perturbed inner retinal
function seen in DR, such as alterations in oscillatory poten-
tials.52
In conclusion, P. obesus represents a potentially valuable
novel animal model of human type 2 DR. Not only is disease
induction (enriched diet) very similar to a major cause of
human type 2 diabetes, but the wide spectrum of retinal
modifications is not seen in other laboratory models and arises
relatively rapidly. Alterations in cone-mediated color vision
constitute one of the earliest characteristics of human DR and
may represent a “biomarker” for early diagnosis. The animal
presents a major advantage in terms of analyzing the patho-
genic mechanisms underlying structural and functional cone
degeneration. We are undertaking functional studies of retinal
visual responses to diabetes and mapping the progression of
retinal changes in respect to the duration of hyperglycemia.
The model will furthermore permit testing of potential thera-
peutic strategies such as insulin treatment, dietary control, and
pharmacologic intervention.
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